DrugPatentWatch Database Preview
Fluticasone furoate - Generic Drug Details
» See Plans and Pricing
What are the generic sources for fluticasone furoate and what is the scope of patent protection?
Fluticasone furoate
is the generic ingredient in four branded drugs marketed by Glaxosmithkline, Glaxosmithkline Cons, and Glaxo Grp Ltd, and is included in four NDAs. There are twenty-seven patents protecting this compound. Additional information is available in the individual branded drug profile pages.Fluticasone furoate has four hundred and three patent family members in forty-one countries.
There are twenty-nine drug master file entries for fluticasone furoate. Two suppliers are listed for this compound.
Summary for fluticasone furoate
International Patents: | 403 |
US Patents: | 27 |
Tradenames: | 4 |
Applicants: | 3 |
NDAs: | 4 |
Drug Master File Entries: | 29 |
Suppliers / Packagers: | 2 |
Bulk Api Vendors: | 25 |
Clinical Trials: | 139 |
Patent Applications: | 1,538 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price trends for fluticasone furoate |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for fluticasone furoate |
DailyMed Link: | fluticasone furoate at DailyMed |
Recent Clinical Trials for fluticasone furoate
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Chiesi Farmaceutici S.p.A. | Phase 4 |
Dr. Grace Parraga | Phase 3 |
Shiraz University of Medical Sciences | N/A |
Pharmacology for fluticasone furoate
Drug Class | Corticosteroid |
Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
US Patents and Regulatory Information for fluticasone furoate
Expired US Patents for fluticasone furoate
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Glaxosmithkline | ARNUITY ELLIPTA | fluticasone furoate | POWDER;INHALATION | 205625-002 | Aug 20, 2014 | Start Trial | Start Trial |
Glaxosmithkline | ARNUITY ELLIPTA | fluticasone furoate | POWDER;INHALATION | 205625-001 | Aug 20, 2014 | Start Trial | Start Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for fluticasone furoate
Country | Patent Number | Estimated Expiration |
---|---|---|
Japan | 4436041 | Start Trial |
Poland | 1786498 | Start Trial |
World Intellectual Property Organization (WIPO) | 2005044354 | Start Trial |
South Africa | 200300929 | Start Trial |
Hungary | E045371 | Start Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for fluticasone furoate
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1519731 | 132013902182575 | Italy | Start Trial | PRODUCT NAME: AZELASTINA CLORIDRATO/FLUTICASONE PROPIONATO(DYMISTA); AUTHORISATION NUMBER(S) AND DATE(S): 2011/07125-REG, 20111024;041808015/M-027/M-039/M-041/M, 20130527 |
1305329 | 326 | Finland | Start Trial | |
1519731 | 92269 | Luxembourg | Start Trial | PRODUCT NAME: AZELASTINE,OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELUICI,ET UN ESTER PHARMACEUTIQUEMENT ACCEPTABLE DE FLUTICASONE |
1305329 | SPC/GB08/026 | United Kingdom | Start Trial | PRODUCT NAME: FLUTICASONE FUROATE AND SOLVATES THEREOF; REGISTERED: UK EU/1/07/434/001 20080111; UK EU/1/07/434/002 20080111; UK EU/1/07/434/003 20080111 |
1305329 | 300343 | Netherlands | Start Trial | 300343, 20210803, EXPIRES: 20230110 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:






Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.